Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Multiple sclerosis rebound following herpes zoster infection and suspension of fingolimod.
Secret talk between adipose tissue and central nervous system via secreted factors-an emerging frontier in the neurodegenerative research.
[A comparison analysis of the use of intravenous β-interferon-1a 30 mcg and subcutaneous β-interferon-1a 44 mcg in routine clinical practice of treatment in patients with multiple sclerosis].
Safety, Tolerability and Efficacy of Monthly Long-acting IM Injection of 80 mg GA Depot in Subjects With RRMS
Reduction of inflammation and preservation of neurological function by anti-CD52 therapy in murine experimental autoimmune encephalomyelitis.
RebiSmart™ (version 1.5) device for multiple sclerosis treatment delivery and adherence.
Pharmaceutical approval update.
Lymphomatoid papulosis type D in a fingolimod-treated multiple sclerosis patient.
A guide to facilitate the early treatment of patients with idiopathic demyelinating disease (multiple sclerosis and neuromyelitis optica).
Expression of cathepsins S and D signals a distinctive biochemical trait in CD34+ hematopoietic stem cells of relapsing-remitting multiple sclerosis patients.
Epstein-Barr virus-specific adoptive immunotherapy for progressive multiple sclerosis.
Narcolepsy with cataplexy and comorbid immunopathological diseases.
Immunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.
Associations of CD6, TNFRSF1A, and IRF8 polymorphisms with risk of inflammatory demyelinating diseases.
Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis - a review.
CD137 ligand activated microglia induces oligodendrocyte apoptosis via reactive oxygen species.
Glossopharyngeal neuralgia secondary to vascular compression in a patient with multiple sclerosis: a case report.
UW-SES: A new self-efficacy scale for people with disabilities.
Vivitrol dosing and administration
Reduced serum orexin-A levels in autoimmune encephalitis and neuromyelitis optica patients.
A phase II study of laquinimod in Crohn's disease.
Multiple Sclerosis: Vitamin D and calcium as environmental determinants of prevalence (A Viewpoint)
Apitope Announces Completion of Enrolment in Phase IIA Clinical Trial of ATX-MS-1467 in Relapsing Multiple Sclerosis
Improvement of internuclear ophthalmoparesis in multiple sclerosis with dalfampridine.
Impact of anti-rheumatic treatment on immunogenicity of pandemic H1N1 influenza vaccine in patients with arthritis.

Pages